Cardiovascular disease testing on the Dimension Vista system: biomarkers of acute coronary syndromes.

@article{Kelley2009CardiovascularDT,
  title={Cardiovascular disease testing on the Dimension Vista system: biomarkers of acute coronary syndromes.},
  author={Walter E. Kelley and Christina M Lockwood and Denise R Cervelli and Jamie Sterner and Mitchell Scott and S J Duh and Robert H M Christenson},
  journal={Clinical biochemistry},
  year={2009},
  volume={42 13-14},
  pages={1444-51}
}
OBJECTIVES Performance characteristics of the LOCI cTnI, CK-MB, MYO, NTproBNP and hsCRP methods on the Dimension Vista System were evaluated. DESIGN AND METHODS Imprecision (following CLSI EP05-A2 guidelines), limit of quantitation (cTnI), limit of blank, linearity on dilution, serum versus plasma matrix studies (cTnI), and method comparison studies were conducted. RESULTS Method imprecision of 1.8 to 9.7% (cTnI), 1.8 to 5.7% (CK-MB), 2.1 to 2.2% (MYO), 1.6 to 3.3% (NTproBNP), and 3.5 to 4… CONTINUE READING
Highly Cited
This paper has 22 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Similar Papers

Loading similar papers…